4-(2,4-Difluorobenzoyl)-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one

Catalog No. :
ACHOZG768
CAS No. :
317822-35-8
Molecular Formula :
C16H12F2N2O2
Molecular Weight :
302.28

IUPAC Name:4-(2,4-difluorobenzoyl)-3-methyl-3,4-dihydroquinoxalin-2(1H)-one

4-(2,4-Difluorobenzoyl)-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2,4-Difluorobenzoyl)-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one
IUPAC Name4-(2,4-difluorobenzoyl)-3-methyl-3,4-dihydroquinoxalin-2(1H)-one
MDL No.MFCD00231343
Molecular FormulaC16H12F2N2O2
Molecular Weight302.28
SMILESO=C1NC2=C(C=CC=C2)N(C(C3=CC=C(F)C=C3F)=O)C1C
InChI KeyARODBLBARKWDRC-UHFFFAOYSA-N
Synonym4-(2,4-DIFLUOROBENZOYL)-3-METHYL-3,4-DIHYDRO-2(1H)-QUINOXALINONE;4-(2,4-difluorobenzoyl)-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one;2(1H)-Quinoxalinone, 4-(2,4-difluorobenzoyl)-3,4-dihydro-3-methyl-
CAS No.317822-35-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHOZG768 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATEN967 route compound structure diagram
    ACATEN96734070-68-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHOZG768 route product structure diagram
    ACHOZG768317822-35-8
Inquiry

2. ACHOZG768 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACATEN967 route compound structure diagram
    ACATEN96734070-68-3 In Stock
  2. Plus
  3. ACLUHV534 route compound structure diagram
    ACLUHV5341765-08-8 In Stock
  4. Then
  5. ACHOZG768 route product structure diagram
    ACHOZG768317822-35-8
Inquiry

Comments (0)